|
|
Volumn 20, Issue 5, 2002, Pages 1041-1047
|
|
MIB-1, p53, bcl-2, and WAF-1 expression in pelvic lymph nodes and primary tumors in early stage cervical carcinomas: correlation with clinical outcome.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CDKN1A PROTEIN, HUMAN;
CELL NUCLEUS ANTIGEN;
CYCLIN DEPENDENT KINASE INHIBITOR 1A;
CYCLINE;
KI 67 ANTIGEN;
NUCLEAR PROTEIN;
PROTEIN BCL 2;
PROTEIN P53;
ARTICLE;
BIOSYNTHESIS;
CARCINOMA;
CELL DIFFERENTIATION;
CELL DIVISION;
DISEASE FREE SURVIVAL;
FEMALE;
HUMAN;
LYMPH NODE;
LYMPH NODE METASTASIS;
METABOLISM;
MORTALITY;
MULTIVARIATE ANALYSIS;
PATHOLOGY;
PELVIS;
PELVIS TUMOR;
PROGNOSIS;
PROPORTIONAL HAZARDS MODEL;
RECURRENT DISEASE;
TIME;
TREATMENT OUTCOME;
UTERINE CERVIX TUMOR;
ANTIGENS, NUCLEAR;
CARCINOMA;
CELL DIFFERENTIATION;
CELL DIVISION;
CYCLIN-DEPENDENT KINASE INHIBITOR P21;
CYCLINS;
DISEASE-FREE SURVIVAL;
FEMALE;
HUMANS;
KI-67 ANTIGEN;
LYMPH NODES;
LYMPHATIC METASTASIS;
MULTIVARIATE ANALYSIS;
NUCLEAR PROTEINS;
PELVIC NEOPLASMS;
PELVIS;
PROGNOSIS;
PROPORTIONAL HAZARDS MODELS;
PROTO-ONCOGENE PROTEINS C-BCL-2;
RECURRENCE;
TIME FACTORS;
TREATMENT OUTCOME;
TUMOR SUPPRESSOR PROTEIN P53;
UTERINE CERVICAL NEOPLASMS;
MLCS;
MLOWN;
|
|
EID: 0036581372
PISSN: 10196439
EISSN: None
Source Type: Journal
DOI: 10.3892/ijo.20.5.1041 Document Type: Article |
|
Times cited : (14)
|
|
References (0)
|
